Daraxonrasib, which nearly doubled patients' survival time, fights the disease in a new way. It bear-hugs a cancer protein that drives cell growth.

The NHS is to roll out the first new ovarian cancer treatment in more than 20 years. The drug has been shown to extend survival by almost four months for patients whose cancer has stopped responding ...

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of ...

The landmark success of a drug against an ‘undruggable’ cancer is spurring fresh optimism in the quest to treat seemingly ...

Although pancreatic cancer remains very lethal, a few new kinds of therapies are coming ...

In the study, patients taking the drug lived longer compared to those undergoing chemotherapy. "This study showed that they ...

Hundreds of women with hard-to-treat ovarian cancer are set to be offered a new treatment following its approval for NHS use.

The FDA has given some patients early access to the drug, daraxonrasib. A study being presented at an oncology conference in ...

Brenda Iveson, from Harrogate, says she feels "very well" after she had the treatment in Leeds.

A new ovarian cancer treatment has been approved for use on the NHS for the first time in 20 years.